Clinical Trial Update: The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema [Phase 2, Phase 3]

View source ↗

Summary

The document reports on a Phase 2/Phase 3 clinical trial evaluating intravitreal erythropoietin injections for refractory diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Refractory Diabetic Macular Edema | Phase 2, Phase 3 | Status: UNKNOWN